{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:38:41Z","timestamp":1761061121801,"version":"3.44.0"},"reference-count":16,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:p>Late-onset sepsis caused by <jats:italic>Staphylococcus aureus<\/jats:italic> is a serious and relatively common complication encountered by preterm neonates in NICUs. Typical treatment regimens for invasive methicillin-sensitive <jats:italic>Staphylococcus aureus<\/jats:italic> (MSSA) include semisynthetic beta lactam antibiotics, such as nafcillin. This report describes the first use of a combination of cefazolin and ertapenem to successfully treat persistent MSSA bacteremia in a preterm neonate who failed traditional first-line therapy.<\/jats:p>","DOI":"10.5863\/1551-6776-25.6.547","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:06:28Z","timestamp":1597417588000},"page":"547-551","source":"Crossref","is-referenced-by-count":4,"title":["Clearance of Persistent Staphylococcus aureus Bacteremia in a Preterm Neonate With the Use of Combination Cefazolin and Ertapenem"],"prefix":"10.5863","volume":"25","author":[{"given":"Stephen M.","family":"Akers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah I.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Mo\u00efse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"2 Pt 1","key":"i1551-6776-25-6-547-b1","series-title":"Pediatrics","first-page":"285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","year":"2002","unstructured":"Stoll\n              BJ\n            , HansenN, FanaroffAA, \n          et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285\u2013291."},{"issue":"3","key":"i1551-6776-25-6-547-b2","series-title":"J Paediatr Child Health","first-page":"294","article-title":"Stable rates of neonatal sepsis in a tertiary neonatal unit","volume":"51","year":"2015","unstructured":"Lean\n              WL\n            , KamlinCO, GarlandSM, JacobsSE.\n          Stable rates of neonatal sepsis in a tertiary neonatal unit. J Paediatr Child Health. 2015;51(3):294\u2013299."},{"issue":"3","key":"i1551-6776-25-6-547-b3","series-title":"Clin Perinatol","first-page":"535","article-title":"Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit","volume":"37","year":"2010","unstructured":"Carey\n              AJ\n            , LongSS.\n          Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit. Clin Perinatol. 2010;37(3):535\u2013546."},{"issue":"12","key":"i1551-6776-25-6-547-b4","series-title":"JAMA Pediatr","first-page":"1105","article-title":"Burden of invasive Staphylococcus aureus infections in hospitalized infants","volume":"169","year":"2015","unstructured":"Ericson\n              JE\n            , PopoolaVO, Brian SmithP, \n          et al. Burden of invasive Staphylococcus aureus infections in hospitalized infants. JAMA Pediatr. 2015;169(12):1105\u20131111."},{"issue":"4","key":"i1551-6776-25-6-547-b5","series-title":"Pediatrics","first-page":"e914","article-title":"Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants","volume":"129","year":"2012","unstructured":"Hale\n              EC\n            , BellEF, StollBJ, \n          et al. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics. 2012;129(4):e914\u2013e922."},{"key":"i1551-6776-25-6-547-b6","series-title":"Staphylococcus aureus.","first-page":"733","year":"2018","unstructured":"American Academy of Pediatrics.\n          Staphylococcus aureus.\n          In: KimberlinDW, BradyMT, JacksonMA, LongSS, eds. Red Book: 2018 Report of the Committe on Infectious Diseases.31st ed. American Academy of Pediatrics; 2018:733\u2013746."},{"issue":"1","key":"i1551-6776-25-6-547-b7","series-title":"J Clin Epidemiol","first-page":"46","article-title":"The CARE guidelines: consensus-based clinical case report guideline development","volume":"67","year":"2014","unstructured":"Gagnier\n              JJ\n            , KienleG, AltmanDG, \n          et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014;67(1):46\u201351."},{"issue":"11","key":"i1551-6776-25-6-547-b8","series-title":"Antimicrob Agents Chemother","first-page":"6609","article-title":"Cefazolin and ertapenem, a synergistic combination used to clear persistent Staphylococcus aureus bacteremia","volume":"60","year":"2016","unstructured":"Sakoulas\n              G\n            , OlsonJ, YimJ, \n          et al. Cefazolin and ertapenem, a synergistic combination used to clear persistent Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2016;60(11):6609\u20136618."},{"issue":"suppl B","key":"i1551-6776-25-6-547-b9","series-title":"J Antimicrob Chemother","first-page":"167","article-title":"A comparison of ampicillin-cefotaxime and ampicillinchloramphenicol in childhood bacterial meningitis: an experience in 55 patients","volume":"14","year":"1984","unstructured":"Lapointe\n              J-R\n            , BeliveauC, ChicoineL, JoncasJH.\n          A comparison of ampicillin-cefotaxime and ampicillinchloramphenicol in childhood bacterial meningitis: an experience in 55 patients. J Antimicrob Chemother. 1984;14(suppl B):167\u2013180."},{"issue":"9","key":"i1551-6776-25-6-547-b10","series-title":"Clin Infect Dis","first-page":"1261","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis","volume":"56","year":"2013","unstructured":"Fern\u00e1ndez-Hidalgo\n              N\n            , AlmiranteB, Gavald\u00e0J, \n          et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56(9):1261\u20131268."},{"issue":"1","key":"i1551-6776-25-6-547-b11","series-title":"Anti-microb Agents Chemother","first-page":"669","article-title":"Ertapenem-containing double-carbapenem therapy for treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"60","year":"2015","unstructured":"Cprek\n              JB\n            , GallagherJC.\n          Ertapenem-containing double-carbapenem therapy for treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae. Anti-microb Agents Chemother. 2015;60(1):669\u2013673."},{"issue":"4","key":"i1551-6776-25-6-547-b12","series-title":"Diagn Microbiol Infect Dis","first-page":"239","article-title":"Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?","volume":"80","year":"2014","unstructured":"Rahme\n              C\n            , ButterfieldJM, NicasioAM, LodiseTP.\n          Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?\n          Diagn Microbiol Infect Dis. 2014;80(4):239\u2013259."},{"issue":"5","key":"i1551-6776-25-6-547-b13","series-title":"Antimicrob Agents Chemother","first-page":"1670","article-title":"Affinity of ceftaroline and other-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae","volume":"54","year":"2010","unstructured":"Kosowska-Shick\n              K\n            , McgheePL, AppelbaumPC.\n          Affinity of ceftaroline and other-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 2010;54(5):1670\u20131677."},{"issue":"suppl D","key":"i1551-6776-25-6-547-b14","series-title":"J Antimicrob Chemother","first-page":"13","article-title":"Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus","volume":"23","year":"1989","unstructured":"Truesdell\n              SE\n            , ZurenkoGE, LabordeAL.\n          Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1989;23(suppl D):13\u201319."},{"issue":"9","key":"i1551-6776-25-6-547-b15","series-title":"Antimicrob Agents Chemother","first-page":"2878","article-title":"Effects of neutrophils on cefazolin activity and penicillin-binding proteins in Staphylococcus aureus abscesses","volume":"46","year":"2002","unstructured":"Bamberger\n              DM\n            , HerndonBL, FitchJ, \n          et al. Effects of neutrophils on cefazolin activity and penicillin-binding proteins in Staphylococcus aureus abscesses. Antimicrob Agents Chemother. 2002;46(9):2878\u20132884."},{"issue":"2","key":"i1551-6776-25-6-547-b16","series-title":"J Chemother","first-page":"67","article-title":"Clinical pharmacology of carbapenems in neonates","volume":"26","year":"2014","unstructured":"Pacifici\n              GM\n            , AllegaertK.\n          Clinical pharmacology of carbapenems in neonates. J Chemother. 2014;26(2):67\u201373."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/6\/article-p547.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/25\/6\/547\/2585592\/1551-6776-25_6_547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/6\/article-p547.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/6\/article-p547.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:39:40Z","timestamp":1747355980000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/6\/article-p547.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-25.6.547","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2020]]}}}